LUT017

N/A

Report date: 2026/03/20 20:03:07
NME

Base Information

Drug NameLUT017
Drug Alias NameLUT-017
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSerine/threonine-protein kinase B-raf inhibitors
TargetsSerine/threonine-protein kinase B-raf
Therapy Area/IndicationsWounds and InjuriesVaricose Ulcer
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesIsrael
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesLutris Pharma
China Registration ClassN/A

Develop Information

Active CompaniesUniversity Of CaliforniaLutris Pharma
Inactive CompaniesN/A
Active IndicationsWounds and InjuriesVaricose Ulcer
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A